【what is yondan aikido】More drugmakers hike U.S. prices as new year begins
By Michael Erman
NEW YORK (Reuters) - Drugmakers including Bristol-Myers Squibb Co
Reuters reported on Tuesday that drugmakers including Pfizer Inc
Nearly all of the price increases are below 10% and the median price increase is around 5%, according to 3 Axis.
More early year price increases could still be announced.
Soaring U.S. prescription drug prices are expected to again be a central issue in the presidential election. President Donald Trump, who made bringing them down a core pledge of his 2016 campaign, is running for re-election in 2020.
Many branded drugmakers have pledged to keep their U.S. list price increases below 10% a year, under pressure from politicians and patients.
The United States, which leaves drug pricing to market competition, has higher prices than in other countries where governments directly or indirectly control the costs, making it the world's most lucrative market for manufacturers.
Drugmakers often negotiate rebates on their list prices in exchange for favorable treatment from healthcare payers. As a result, health insurers and patients rarely pay the full list price of a drug.
Bristol-Myers said in a statement it will not raise list prices on its drugs by more than 6% this year.
The drugmaker raised the price on 10 drugs on Wednesday, including 1.5% price hikes on cancer immunotherapies Opdivo and Yervoy and a 6% increase on its blood thinner Eliquis, all of which bring in billions of dollars in revenue annually.
It also raised the price on Celgene's flagship multiple myeloma drug, Revlimid, 6%. Bristol acquired rival Celgene in a $74 billion deal last year.
Gilead raised prices on more than 15 drugs including HIV treatments Biktarvy and Truvada less than 5%, according to 3 Axis.
Biogen price increases included a 6% price hike on multiple sclerosis treatment Tecfidera, according to 3 Axis.
Gilead and Biogen could not be immediately reached for comment.
3 Axis advises pharmacy industry groups on identifying inefficiencies in the U.S. drug supply chain and has provided consulting work to hedge fund billionaire John Arnold, a prominent critic of high drug prices.
(Reporting by Michael Erman; Editing by Nick Zieminski)
View comments
-
Akoustis Reports Third Quarter FY20 ResultsBRIEF-Zhejiang Jiahua Energy Chemical Says Is Warned By Regulator For Violation Of Information DisclosureShould You Be Impressed By China Nonferrous Mining Corporation Limited’s (HKG:1258) ROE?Bitcoin Price Celebrates New Year Inside a Near-Term Descending ChannelDonald Trump vows 'major' steps to aid US economy amid coronavirus rise‘FLTR’ ETF an Effective Countermove for Rising RatesNigeria's Kaduna refinery expected to resume by mid-April - NNPCHow Financially Strong Is Anglo African Agriculture Plc (LON:AAAP)?SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RTI Surgical Holdings, Inc. - RTIXBitcoin Cash: Single Mining Pool Controls 50% of Hashrate
下一篇:How Much Is Live Nation Entertainment, Inc. (NYSE:LYV) CEO Getting Paid?
- ·A village of tiny Victorian homes offers a life-changing experience
- ·Wednesday Newspaper
- ·Former Judge Randy Wilson Returns to Susman Godfrey After 15 Years on Bench
- ·What Should You Know About The Future Of AstraZeneca PLC’s (LON:AZN)?
- ·Sun Summit Minerals Phase 2 Drilling Update and Completion of IP Survey at the Buck Property
- ·Disney Infinity Expansion Includes More Marvel and Star Wars
- ·Do Directors Own Luk Hing Entertainment Group Holdings Limited (HKG:8052) Shares?
- ·Zoo animals still need to be fed despite government shutdown
- ·Pfizer-BioNTech seeks full marketing approval from UK for COVID-19 vaccine
- ·Cosmose Continues to Revolutionize Global Advertising With Launch of Its OMNIcookie Technology in U.S.
- ·When Should You Buy Hancock Whitney Corporation (NASDAQ:HWC)?
- ·7 of Hillary Clinton’s Biggest Flip-Flops
- ·Exclusive: Germany ready to nationalise airline Condor - sources
- ·Kim Kardashian's Met Gala After Party Was a Slice of Pizza and a Hotel Room Photo Shoot
- ·Bitcoin Cash: Single Mining Pool Controls 50% of Hashrate
- ·READ NOW: Monteverde & Associates PC Launches an Investigation of the Board of Directors and Officers of Community First Bank– CMYF
- ·TUI Will Cut Budgets, Freeze Hiring to Deal With Coronavirus Spread
- ·Singapore fourth quarter GDP growth cools as trade woes darken outlook
- ·Some Love For a Tattered Industrials ETF
- ·Are Casta Diva Group S.p.A.’s (BIT:CDG) Interest Costs Too High?
- ·Insider Buying: The Domino's Pizza Group plc (LON:DOM) CEO & Director Just Bought UK£201k Worth Of Shares
- ·Data Sheet—Burning Cash With China's Meituan-Dianping Delivery Service
- ·Malaysian palm producer FGV appoints new chief financial officer
- ·A More Inclusive Language
- ·Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Groupon, Inc. (GRPN)
- ·How Much Are MTY Food Group Inc. (TSE:MTY) Insiders Taking Off The Table?
- ·The Global Virtualization in Industrial Automation Market is expected to grow by $ 216.39 mn during 2020-2024 progressing at a CAGR of 4% during the forecast period
- ·Ardagh Group (ARD) Looks Good: Stock Adds 5.8% in Session
- ·‘Wayne’s World’ Director Penelope Spheeris Reveals How the Iconic ‘Bohemian Rhapsody’ Scene Came to Be
- ·Kellie Pickler shaves her head: PHOTO
- ·Amazon's (AMZN) Latest ML Services Boost Its AWS Portfolio
- ·South Koreans seek Nippon Steel asset seizure in 'forced labour' case
- ·GM sold 200,000 electric vehicles in U.S. by 2018, triggering tax-credit phaseout - source
- ·China's Jangho makes $1.2 bln bid for Australian medical centre owner Healius
- ·Can Ero Copper Corp. (TSE:ERO) Maintain Its Strong Returns?
- ·Why Netgear Stock Dropped Today